Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

President Donald Trump signed an executive order on the healthcare sector yesterday, aiming to lower prescription drug prices for Americans, ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price ...

In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas (“District Court ...

A newly approved antibiotic to treat urinary tract infections, gepotidacin, also may help fight drug-resistant gonorrhea, a new study shows.

Proposed tariffs on pharmaceutical imports could destabilize U.S. generic drug supply, warns Dr. Scott Gottlieb.

The Department of Commerce launched an investigation on April 1 into the national security impacts of importing drugs and ...

The National Institute for Standards and Technology’s new harm reduction initiative is helping prevent needless deaths.

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...